Records containing: Leukoplakia, Oral
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-04-22Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia
-
CLINICAL_TRIALS study record update · 2024-03-07Comparison Between Surgical Excision and "Wait and See" Approach in the Treatment of Oral Leukoplakia: a Randomized, Controlled Clinical Trial
-
CLINICAL_TRIALS study record update · 2023-09-13Diagnostic Accuracy of lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially Malignant Lesions
-
CLINICAL_TRIALS study record update · 2021-10-19A Phase 1, Randomized, Double-blind, Placebo Controlled, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of SBS-101 After Intraoral Application in Patients With Oral Premalignant Lesions (OPL)
-
CLINICAL_TRIALS study record update · 2021-08-12Clinical Evaluation of the OncAlert RAPID; Impact on Decision-Making
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-11-19A Pilot Multi-Center International Double-Blind Placebo Controlled Randomized Study of Sulindac, a Pan-Cox Inhibitor, in Oral Premalignant Lesions